Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A STOLK

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Advances in Parasitology|March 14, 2015
Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directionsWilma A Stolk, Chris Stone, Sake J de Vlas
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT frameworkNan Luo, Minghui Li, Elly A Stolk, et al.
BMJ Global Health|June 8, 2017
Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in AfricaYoung Eun Kim, Wilma A Stolk, Marcel Tanner, et al.
Nature Communications|February 6, 2024
Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapyLuc E Coffeng, Wilma A Stolk, Sake J de Vlas
Magnetic Resonance in Medicine|September 1, 1994
In vivo 31P NMR studies of orientation effects upon rat brain metabolism during mild hypoxiaM Chen, J A Stolk, J I Olsen, et al.
Trends in Parasitology|June 30, 2009
The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic FilariasisErling M Pedersen, Wilma A Stolk, Sandra J Laney, et al.
Filaria Journal|March 30, 2006
Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modellingWilma A Stolk, Sake J de Vlas, J Dik F Habbema
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 10, 2010
Discrete choice modeling for the quantification of health states: the case of the EQ-5DElly A Stolk, Mark Oppe, Luciana Scalone, et al.
Epidemics|March 11, 2017
Measuring and modelling the effects of systematic non-adherence to mass drug administrationLouise Dyson, Wilma A Stolk, Sam H Farrell, et al.
Health Policy (Amsterdam, Netherlands)|January 12, 2002
Rationalising rationing: economic and other considerations in the debate about funding of ViagraElly A Stolk, Werner B F Brouwer, Jan J V Busschbach
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Advances in Parasitology|March 14, 2015
Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directionsWilma A Stolk, Chris Stone, Sake J de Vlas
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT frameworkNan Luo, Minghui Li, Elly A Stolk, et al.
BMJ Global Health|June 8, 2017
Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in AfricaYoung Eun Kim, Wilma A Stolk, Marcel Tanner, et al.
Nature Communications|February 6, 2024
Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapyLuc E Coffeng, Wilma A Stolk, Sake J de Vlas
Magnetic Resonance in Medicine|September 1, 1994
In vivo 31P NMR studies of orientation effects upon rat brain metabolism during mild hypoxiaM Chen, J A Stolk, J I Olsen, et al.
Trends in Parasitology|June 30, 2009
The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic FilariasisErling M Pedersen, Wilma A Stolk, Sandra J Laney, et al.
Filaria Journal|March 30, 2006
Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modellingWilma A Stolk, Sake J de Vlas, J Dik F Habbema
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 10, 2010
Discrete choice modeling for the quantification of health states: the case of the EQ-5DElly A Stolk, Mark Oppe, Luciana Scalone, et al.
Epidemics|March 11, 2017
Measuring and modelling the effects of systematic non-adherence to mass drug administrationLouise Dyson, Wilma A Stolk, Sam H Farrell, et al.
Health Policy (Amsterdam, Netherlands)|January 12, 2002
Rationalising rationing: economic and other considerations in the debate about funding of ViagraElly A Stolk, Werner B F Brouwer, Jan J V Busschbach
Pageof 17